Morocco has postponed the implementation of a new drug pricing system, initially scheduled for review on July 9th. The system was intended to replace the existing price controls from 2013. The delay's cause remains officially unconfirmed, sparking speculation within the sector. Suspicions point to pressure from multinational pharmaceutical companies and the absence of key government officials during a crucial council meeting. Political considerations are also being cited as a potential factor. Several hypotheses are circulating, but no official explanation has been provided regarding the unexpected postponement. This delay leaves the future of drug pricing regulations in Morocco uncertain.